Bullish Moving Averages
11
Bearish Moving Averages
5
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Open Price
24.20Prev. Close
21.4000Volume
244403.00Value
6007425.74Fundamentals
Market Cap
123.10
Price to Earnings
-5.70
Price to Book Value
1.30
Dividend Yield
0.00
PE to Growth
-0.10
Op Revenue TTM
104.34
Net Profit TTM
-21.73
Cash From Operating Activity
2.14
Return on Equity %
-22.47
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
65.6
Week
67.1
Month
70.7
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
24.48
PIVOT
First Resistance
25.40
Second Resistance
26.22
Third Resistance
27.14
First Support
23.66
Second Support
22.74
Third Support
21.92
Relative Strength Index
64.76
Money Flow Index
63
MACD
0.16
MACD Signal
-0
Average True Range
1.03
Average Directional Index
15.35
Rate of Change (21)
19.9
Rate of Change (125)
-21.97
Commodity Channel Index
274.9
Williams %R
-20.6
BETA
1 Month
1.51
3 Month
0.84
1 Year
0.62
3 Year
0.32
PRICE CHANGE ANALYSIS
↑ 6.22%
1 Week
Low
High
22.5
25.3
↑ 14.86%
1 Month
Low
High
21.8
25.4
↓ -9.13%
3 Months
Low
High
19
28
↓ -31.24%
6 Months
Low
High
19
41.2
↑ 8.52%
1 Year
Low
High
19
41.2
29 Jun 2024
Lasa Supergenerics Ltd - 540702 - Closure of Trading Window
This is to inform you that as per the Company''s code of conduct for Regulating, Monitoring and Reporting of Trading by insiders in term of (Prohibition of Insider Trading) Regulations, 2015 as amended, the Trading window for dealing in the equity shares of the company has been closed for designated employees and their immediate relatives wef July 01, 2024 till 48 hours after conclusion of unaudited Financial results (both days inclusive) for the Quarter ended June 30,2024
26 Jun 2024
Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
We wish to inform you that the Member of the company has approved by the way postal Ballot the following resolutions under companies act 2013 read with SEBI Listing Regulation as set out in the Notices of postal Ballot Dated May 22 2024 with Requisite Majority Item No 1 Appointment of Mr. Umesh Pawar Din 10539778 as the Whole Time Director Designated as Executive Director for the term of 5 year commencing from March 08, 2024 As per Scrutinizer Report dated Wednesday June 26 2024 the aforesaid resolution has been passed with requisite majority on Wednesday June 26 2024
26 Jun 2024
Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
We wish inform you that the member of the compnay has approved the the way of postal ballot the following resolution under companies act 2013 read with SEBI listing regulation res out in the notice of postal ballot Dated May 22 2024 with Requisite Majority item No 1 Appointment of Umesh Pawar Din 10539778 as the whole time Director designated as Executive Director for the term of 5 years from 08th March 2024 As per Scrutinizer report dated Wednesday June 26 2024 the aforesaid resolution has been passed with requisite Majority on Wednesday June 26 2024
21 Jun 2024
The menace of LASA drugs
The very existence of countless misleading brand names shows that India's drug regulator, Central Drugs Standard Control Organisation (CDSCO), is not doing what it is tasked to do, a recent study in Lancet Regional Healthnoted.
30 May 2024
Lasa Supergenerics Ltd - 540702 - Disclosure Of Related Party Transaction Under Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
Pursuant to Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015 Please find enclosed herewith disclosure of Related Party Transaction for the year ended March 31 2024
30 May 2024
Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Board Meeting
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 8.00 p.m. and concluded at 10.45 p.m. inter- alia have considered and approved the following: The statement of Audited Financial Results of the Company for the quarter and the financial year ended on March 31, 2024 A copy of the statement of audited Financial Results, Cash Flow statement along with Audited Report submitted by the Statutory Auditors of the Company is attached herewith
29 May 2024
Lasa Supergenerics Ltd - 540702 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to SEBI circular CIR/CFD/CMD1/27/2019 Dated 8th February , 2019 ,please find enclosed copy of Annual Secretarial Compliance Report dated 27th May, 2024 issued by Shivam Sharma & Associates for the FY - 2023-24
24 May 2024
Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for For The Quarter And Year Ended March 31St, 2024
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 30, 2024, inter alia; 1. To consider, approve and take on records Audited financial results of the Company for the quarter and the year ended March 31, 2024. 2. To discuss any other matter with the permission of the Chairperson.
22 May 2024
Lasa Supergenerics Ltd - 540702 - Notice Of Postal Ballot, Seeking Shareholders' Approval For Appointment Of Mr. Umesh Pawar As Executive Director
Pursuant to Regulation 30 of Securities Exchange Board Of India (Listing Obligation and Disclosure Requirement) Regulation, 2015, we enclosed herewith postal Ballot Notice, Seeking Approval of Member of the Company
30 Apr 2024
Lasa Supergenerics Ltd - 540702 - Declaration With Respect To Non -Applicability Of Large Entities Framework Pursuant To SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November, 2018
Pursuant to circular No SEBI/HO/DDHS/CIP/P/2018/144 dated 26th November, 2018 for fund raising by issuances of debt Securities by large entities and Compliance thereof we hereby submit that our company is out of the purview of Large Corporate category as per the applicability of framework provided in the aforesaid Circular
